Cardiovascular Systems Completes $29 Million Debt Facility with Silicon Valley Bank and Partners for Growth
April 20 2010 - 4:05PM
Business Wire
Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), announced
today that it has established a $25 million credit facility with
Silicon Valley Bank and up to $4 million in convertible debt with
Partners for Growth. Proceeds will be used to consolidate existing
outstanding debt, provide working capital for growth and for
general corporate purposes.
“This financing enhances the company’s financial flexibility as
we continue to grow our business and work toward profitability and
positive cash flow,” said David L. Martin, president and CEO of
Cardiovascular Systems. “We are focused on advancing our priorities
for growth: expanding adoption of the Diamondback 360® for
treatment of peripheral arterial disease (PAD), conducting
prospective PAD clinical trials, introducing enhanced versions of
the Diamondback 360° and expanding our technology for use in the
coronary market.”
The Silicon Valley Bank facility consists of a $10 million
growth capital term loan and a $15 million line of credit for
working capital. The Partners for Growth convertible debt provides
the ability to draw up to $4 million in the first 12 months and
additional funds over the subsequent four years to the extent debt
is converted to common stock. Upon closing the transaction, $1.5
million of convertible debt was drawn by CSI. In addition, CSI
issued Partners for Growth a warrant for up to 147,330 shares of
its common stock at $5.43 per share.
About Cardiovascular Systems, Inc.
Cardiovascular Systems Inc., (CSI) (Nasdaq: CSII) based in St.
Paul, Minn., is a medical device company focused on providing
clinically proven, safe and effective solutions for vascular
disease. The company’s Diamondback 360® PAD System removes
calcified and fibrotic plaque in small and large peripheral
vessels, and addresses many of the limitations associated with
existing surgical, catheter and pharmacological treatment
alternatives. In August 2007, the U.S. FDA granted 510(k) clearance
for the use of the Diamondback 360° as a therapy for PAD, and CSI
commenced a U.S. product launch in September 2007. Since then, more
than 20,000 procedures have been performed using the system. For
more information visit the company’s Web site at
www.csi360.com.
About Silicon Valley Bank
For nearly 30 years, SVB Financial Group and its subsidiaries,
including Silicon Valley Bank, have been dedicated to helping
entrepreneurs succeed. SVB Financial Group is a financial holding
company that serves companies in the technology, life science,
venture capital/private equity and premium wine industries.
Offering diversified financial services through Silicon Valley
Bank, SVB Analytics, SVB Capital, SVB Global and SVB Private Client
Services, SVB Financial Group provides clients with commercial,
investment, international and private banking services. SVB also
offers funds management, broker-dealer services, asset management
and a wide range of financial services for companies of all sizes
and stages, as well as the added value of its knowledge and
networks worldwide. Headquartered in Santa Clara, California, SVB
Financial Group operates through 27 offices in the U.S. and
operations in China, India, Israel and the United Kingdom. More
information on the SVB Financial Group can be found at
www.svb.com.
About Partners for Growth
Partners for Growth (PFG) provides custom debt solutions to
private and public emerging growth technology and life science
companies. On the technology side, PFG has been focusing on
late-stage companies ($10 million and above in revenue) and
customizes its financing to match the needs of the
company. PFG’s custom approach results in a variety of
structures and terms including working capital lines of credit,
term loans and convertible debt. PFG looks to share in the
success of its clients by taking equity participation rights in the
form of stock warrants or convertibility of its debt.
PFG is organized as three private partnerships with over $150
million under management. SVB Financial Group (NASDAQ: SIVB),
the parent company of Silicon Valley Bank, is the largest limited
partner in Partners for Growth. PFG works closely with Silicon
Valley Bank, whereby PFG can provide incremental debt solutions to
many of the Bank’s clients.
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From May 2024 to Jun 2024
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Jun 2023 to Jun 2024